Algorithmiq, a quantum software company previously based in Finland, has established its global headquarters in Milan, Italy. The relocation follows an €18 million ($21.2 million USD) funding round—the largest-ever venture capital investment in an Italian quantum startup—led by United Ventures and the Italian institutional investor Cassa Depositi e Prestiti (CDP), with continued participation from Inventure VC. This brings the company’s total funding to €36 million ($42.4 million USD) and signals a strategic commitment to Italy as a hub for the industrialization of quantum algorithms.
The move aligns with Italy’s National Quantum Strategy, launched in 2025, which aims to build a robust quantum infrastructure and bridge the gap between academic research and commercial deep-tech applications. By situating itself in Milan, Algorithmiq aims to leverage Europe’s scientific talent pool and Italy’s historic foundations in physics to focus on the software layer of the quantum stack. The company’s leadership emphasizes that while hardware advancements are essential, algorithmic efficacy is the primary requirement for transforming quantum machines into tools with industrial value.
Major Technical and Commercial Milestones
Algorithmiq has recently achieved several “world-first” milestones in the life sciences and materials sectors:
- Wellcome Leap Q4Bio Winner: Algorithmiq was named the sole winner of the $2 million Q4Bio Challenge, outperforming finalists from Harvard, Oxford, and Stanford. The team demonstrated a scalable end-to-end quantum-classical workflow on 100 qubits to simulate photodynamic therapy for cancer, representing a credible path toward quantum advantage in drug discovery.
- Verified Quantum Advantage: In 2025, the company achieved quantum advantage for a useful scientific problem—the simulation of heterogeneous quantum materials—using its proprietary models on IBM quantum hardware. The results were benchmarked against state-of-the-art classical methods from the Flatiron Institute.
- Global Partnerships: Algorithmiq has secured major commercial agreements with IBM, Microsoft, and Rigetti, and its noise-mitigation algorithms are now featured in the Qiskit Functions catalog, making them accessible to researchers worldwide.
Focus on Industrial Execution
Under the leadership of CEO Dr. Sabrina Maniscalco, Algorithmiq is moving toward “utility-scale” hardware validation. Rather than competing in the capital-intensive hardware race, the company provides the software layer that enables researchers at organizations like CERN and the Cleveland Clinic to execute physically meaningful, energy-efficient computations. The establishment of the Milan headquarters is intended to scale these operations globally, positioning Europe as a leader in making quantum computers practically useful for chemistry, materials science, and complex therapeutics.
You can find the official announcement regarding Algorithmiq’s relocation and funding here. For more information on the strategic decision to choose Italy, refer to the investor’s note from United Ventures here. Additional details on their Wellcome Leap Q4Bio win can be found here.
May 11, 2026
Leave A Comment